Determination of factor X activator in the venom of the saw-scaled viper (Echis carinatus)

Factor X activator in Echis carinatus venom was determined by incubating the zymogen 'factor X' with venom, interrupting the activation process by ethylenediaminetetraacetic acid and measuring the generated proteinase 'factor Xa' by means of a synthetic chromogenic substrate. A comparison of factor X- and prothrombin-activating potencies in E. carinatus venoms of five different geographic origins revealed no correlation between these two procoagulant activities.     

Force behaviour of elastic chains during a simulated gap closure in extraction therapy cases

Objective

Tooth movement with elastic chains requires defined force magnitudes. This study assessed the force behaviour of different elastic chains at different configurations of gap width.

Methods

Self-ligating brackets of teeth 5 & 6 and 2 & 3 were bonded to two movable aluminium plates. The plates were positioned on a joint basis with varying distances of 0.5, 2.0, 4.0, 6.0, and 8.0 mm. Reset forces of open and closed chains from four different manufacturers were investigated in four different configurations. Configurations differed in either having an additional intermediate ring within the gap (#1, #3) and/or having intermediate rings between teeth adjacent to the gap (#1, #2), or by no intermediate rings (#4). Forces were measured with a universal testing machine. The results were statistically analysed using U-test, H-test and (if applicable) post-hoc tests with a significance level of .05.

Results

Configurations #1 and #3, and #2 and #4 formed homogenous subgroups (P < .001). Initial forces in configuration #4 were significantly higher than in configuration #3 (P = .029). Initial forces in closed chains were significantly higher than for open chains (P = .029).

Conclusions

Intermediate chain rings adjacent to the gap are not required to modulate the force. In contrast, leaving a ring unapplied in the tooth gap can help modulate the force. Open thermoset chains with an additional ring within the gap (#3) seem to produce suitable initial forces for a gap closure of 4 mm. With a residual gap width of <2 mm, open thermoset chains and closed thermoset chains (#4) seem suitable.     

Cardio-hepatic syndrome in patients undergoing mitral valve transcatheter edge-to-edge repair

Aims

The impact of the cardio-hepatic syndrome (CHS) on outcomes in patients undergoing mitral valve transcatheter edge-to-edge repair (M-TEER) for relevant mitral regurgitation (MR) is unknown. The objectives of this study were three-fold: (i) to characterize the pattern of hepatic impairment, (ii) to investigate the prognostic value of CHS, and (iii) to evaluate the changes in hepatic function after M-TEER.

Methods and results

Hepatic impairment was quantified by laboratory parameters of liver function. In accordance with existing literature, two types of CHS were distinguished: ischaemic type I CHS (elevation of both transaminases) and cholestatic type II CHS (elevation of two out of three parameters of hepatic cholestasis). The impact of CHS on 2-year mortality was evaluated using a Cox model. The change in hepatic function after M-TEER was assessed by laboratory testing at follow-up. We analysed 1083 patients who underwent M-TEER for relevant primary or secondary MR at four European centres between 2008 and 2019. Ischaemic type I and cholestatic type II CHS were observed in 11.1% and 23.0% of patients, respectively. Predictors for 2-year all-cause mortality differed by MR aetiology. While in primary MR cholestatic type II CHS was independently associated with 2-year mortality, ischaemic CHS type I was an independent mortality predictor in secondary MR patients. At follow-up, patients with MR reduction ≤2+ (obtained in 90.7% of patients) presented with improved parameters of hepatic function (median reduction of 0.2 mg/dl, 0.2 U/L and 21 U/L for bilirubin, alanine aminotransferase and gamma-glutamyl transferase, respectively, p < 0.01).

Conclusions

The CHS is frequently observed in patients undergoing M-TEER and significantly impairs 2-year survival. Successful M-TEER may have beneficial effects on CHS.